Home
Divis Laboratories Ltd PE Ratio
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fdivis-laboratories-ltd.png&w=128&q=75)
Divis Laboratories Ltd
NSE: DIVISLAB
PE
Key Highlights
- The P/E Ratio of Divis Laboratories Ltd is 76.6 as of 12 Feb 15:30 PM .
- The P/E Ratio of Divis Laboratories Ltd changed from 38.3 on March 2020 to 56.9 on March 2024 . This represents a CAGR of 8.24% over 5 years.
- The Latest Trading Price of Divis Laboratories Ltd is ₹ 5966 as of 12 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Divis Laboratories Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Divis Laboratories Ltd
Company Fundamentals for Divis Laboratories Ltd
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fdivis-laboratories-ltd.png&w=128&q=75)
Divis Laboratories Ltd
NSE: DIVISLAB
Share Price
Market Price of Divis Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
12 Feb 2025 | 5966.65 |
11 Feb 2025 | 5949.15 |
10 Feb 2025 | 5931 |
07 Feb 2025 | 6140.45 |
06 Feb 2025 | 6116.9 |
05 Feb 2025 | 6124.4 |
04 Feb 2025 | 6092.2 |
03 Feb 2025 | 5889.3 |
01 Feb 2025 | 5622.3 |
31 Jan 2025 | 5575.9 |
SWOT Analysis Of Divis Laboratories Ltd
BlinkX Score for Divis Laboratories Ltd
Asset Value vs Market Value of Divis Laboratories Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Divis Laboratories Ltd | 158395 | 76.63 |
Sun Pharmaceuticals Industries Ltd | 406363 | 34.5 |
Cipla Ltd | 117088 | 23.5 |
Torrent Pharmaceuticals Ltd | 103663 | 55.7 |
Dr Reddys Laboratories Ltd | 101458 | 18.9 |
Mankind Pharma Ltd | 99897 | 48.9 |
Company | |
---|---|
Divis Laboratories Ltd | 158395 |
Sun Pharmaceuticals Industries Ltd | 406363 |
Cipla Ltd | 117088 |
Torrent Pharmaceuticals Ltd | 103663 |
Dr Reddys Laboratories Ltd | 101458 |
Mankind Pharma Ltd | 99897 |
PE Ratio of Divis Laboratories Ltd Explained
₹158395
Market cap
₹2067
Earnings
76.6X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Divis Laboratories Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Divis Laboratories Ltd
Historical Revenue, EBITDA and Net Profit of Divis Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Divis Laboratories Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Divis Laboratories Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Divis Laboratories Ltd
About Divis Laboratories Ltd
- Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
- The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
- It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
- In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
- It is among the largest pharmaceutical companies in India with a portfolio of approx.
Divis Laboratories Ltd News Hub
Divis Laboratories Ltd rises for third straight session
Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at Rs 4884.75,
Read more
21 Aug 24
Divis Lab Q1 PAT climbs 21% YoY to Rs 430 cr
Revenue from operations grew by 19.12% year on year to Rs 2,118 crore in the quarter ended 30 June 2
Read more
03 Aug 24
Divi's Laboratories consolidated net profit rises 20.79% in the June 2024 quarter
Net profit of Divi's Laboratories rose 20.79% to Rs 430.00 crore in the quarter ended June 2024 as a
Read more
03 Aug 24
Divis Laboratories Ltd up for third straight session
Divis Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 5151.7,
Read more
05 Sept 24